A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm Adherium, ...
Mycobacterium smegmatis porin A (MspA) modified with nitrilotriacetic acid achieves direct and simultaneous discrimination of rare-earth elements, suggesting the potential use of nanopore sensing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback